نمایش مختصر رکورد

dc.date.accessioned1399-07-08T18:14:30Zfa_IR
dc.date.accessioned2020-09-29T18:14:30Z
dc.date.available1399-07-08T18:14:30Zfa_IR
dc.date.available2020-09-29T18:14:30Z
dc.date.issued2014-12-01en_US
dc.date.issued1393-09-10fa_IR
dc.identifier.citation(2014). Age and Survival of Cervical Cancer Patients with Bone Metastasis. Asian Pacific Journal of Cancer Prevention, 15(19), 8401-8404.en_US
dc.identifier.issn1513-7368
dc.identifier.issn2476-762X
dc.identifier.urihttp://journal.waocp.org/article_29932.html
dc.identifier.urihttps://iranjournals.nlai.ir/handle/123456789/39477
dc.description.abstract<b>Background:</b> To determine survival times of cervical cancer patients with bone metastasis related to theeffect of age at the time of cervical cancer diagnosis, we performed the retrospectively analytical study. <br/><b>Methods</b>:A total of 68 cervical cancer patients with bone metastasis were treated at a single hospital, during January1998 to December 2010. Fifty-two medical records were identified and collected, the remaining sixteen medicalrecords were not found. Main outcome measures were patient characteristics, clinical information, duration fromcervical cancer diagnosis to bone metastasis diagnosis, survival time after bone metastasis and overall survivaltime. <br/><b>Results</b>: Among fifty-two cervical cancer patients with bone metastasis, there were 13 patients who wereless than 45 years old, and 39 patients were 45 years old or more at the time of cervical cancer diagnosis. Theyounger group had less median overall survival than the older group, with a statistically significant difference(21 months, 95% CI 19.93-22.06; 34 months, 95% CI 23.27-44.72, p = 0.021). However, they were comparablein the duration from cervical cancer diagnosis to bone metastasis diagnosis and the survival time after bonemetastasis. <br/><b>Conclusion</b>: Young patients with bone metastasis aged less than 45 years old at the time of cervicalcancer diagnosis have a poorer prognosis than the elderly patients. Impact: To improve survival and quality oflife, more intensive and novel multimodal treatments at the time of cervical cancer diagnosis should be consideredin patients less than forty-five years, who can tolerate the side effects better.en_US
dc.format.extent360
dc.format.mimetypeapplication/pdf
dc.languageEnglish
dc.language.isoen_US
dc.publisherWest Asia Organization for Cancer Prevention (WAOCP)en_US
dc.relation.ispartofAsian Pacific Journal of Cancer Preventionen_US
dc.subjectcervical canceren_US
dc.subjectbone metastasisen_US
dc.subjectageen_US
dc.subjectsurvivalen_US
dc.titleAge and Survival of Cervical Cancer Patients with Bone Metastasisen_US
dc.typeTexten_US
dc.citation.volume15
dc.citation.issue19
dc.citation.spage8401
dc.citation.epage8404


فایل‌های این مورد

Thumbnail

این مورد در مجموعه‌های زیر وجود دارد:

نمایش مختصر رکورد